We found that tumor-infiltrating γδT cells in the high-dose treatment group can only exert immunosuppressive effects in the presence of neutrophils, and this effect can be antagonized by IL17A mAb (Figures 6D, E). The gene discussed is IL17A; the disease is neoplasm.